A carregar...
Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice
Imatinib, a PDGF receptor tyrosine kinase inhibitor, has been shown to suppress intimal hyperplasia in different animal models under normal metabolic milieu, diabetic, and/or hypercholesterolemic conditions. However, the impact of imatinib treatment on injury-induced neointimal hyperplasia has not y...
Na minha lista:
| Publicado no: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749815/ https://ncbi.nlm.nih.gov/pubmed/33131722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173666 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|